טוען...
Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
BACKGROUND: Maintenance of remission is a major issue in the management of Crohn's disease. Thalidomide, a tumour necrosis factor‐alpha (TNF‐α) inhibitor and its analogue, lenalidomide, may have a role in the management of Crohn's disease, but it is not clear whether it is an effective mai...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2009
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7207562/ https://ncbi.nlm.nih.gov/pubmed/19370685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007351.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|